Andreas Hartkopf

Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial

Markus Wallwiener, Lina Maria Matthies, Elisabeth Simoes et al. · Journal of Medical Internet Research · 2017 · 62 citations · Full text

Pharmacy, Oncology, Health Assessment +15

Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer

Vincent Walter, C Fischer, Thomas M. Deutsch et al. · Breast Cancer Research and Treatment · 2020 · 60 citations · Full text

Medicine, Endocrinology, Oncology +15

Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studies

J Salmen, Julia Neugebauer, Peter A. Fasching et al. · Breast Cancer Research and Treatment · 2014 · 59 citations

Medicine, Endocrinology, Gynecology +8

Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer Patients

Andreas Hartkopf, Joachim Graf, Elisabeth Simoes et al. · JMIR Cancer · 2017 · 52 citations · Full text

Pharmacy, Health Informatics, Oncology +13

Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers

Olaf Ortmann, Jens‐Uwe Blohmer, Nora Tabea Sibert et al. · Journal of Cancer Research and Clinical Oncology · 2022 · 48 citations · Full text

Medicine, Oncology, Breast Oncology +12